CME Group Inc. (NASDAQ:CME) Holdings Lowered by Peoples Bank KS

Peoples Bank KS cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,325 shares of the financial services provider’s stock after selling 60 shares during the quarter. Peoples Bank KS’s holdings in CME Group were worth $954,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital International Investors grew its position in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. grew its position in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after acquiring an additional 1,309,097 shares during the period. M&G Plc acquired a new stake in shares of CME Group during the 1st quarter worth about $156,631,000. Assenagon Asset Management S.A. boosted its holdings in shares of CME Group by 577.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after acquiring an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of a number of analyst reports. The Goldman Sachs Group lifted their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft increased their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. TD Cowen started coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Bank of America raised their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $213.77.

CME Group Trading Up 0.1 %

Shares of CME traded up $0.16 during mid-day trading on Friday, reaching $224.43. The company’s stock had a trading volume of 1,585,724 shares, compared to its average volume of 1,959,577. The stock has a market cap of $80.81 billion, a PE ratio of 25.51, a P/E/G ratio of 8.74 and a beta of 0.55. The company’s fifty day moving average price is $211.69 and its two-hundred day moving average price is $207.71. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $226.78. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share. The business’s revenue was up 12.7% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.